MTX

(redirected from methotrexate)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
AcronymDefinition
MTXMethotrexate
MTXMultiple Text
MTXMicrosoft Transaction Server
MTXMts Surrogate
MTXManual Transmission
MTXManual Transmission (automobile)
MTXMr T Experience (rock band)
MTXMobile Telephone Exchange
MTXManual Transaxle (Automotive)
MTXMaster of Taxation
MTXMicro-Transaction
MTXMobile Transmitter
MTXMilitary Traffic Expediting Service
MTXMorrell Tank Line (Railroad)
References in periodicals archive ?
The recommendations result from a review of reports that patients are using methotrexate incorrectly despite previous measures to prevent errors.
The trial is to evaluate if the combination of KRYSTEXXA with methotrexate can improve the demonstrated response rate of the product and to confirm the safety and tolerability and offer information on the pharmacokinetics of the combined use.
The CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcome Study) results with canakinumab and the new results with methotrexate "demonstrate that inflammation inhibition [with canakinumab] can significantly reduce cardiovascular event rates independent of lipid lowering and blood pressure reduction," Paul M.
The secondary endpoint of minimal disease activity response at week 24 also was significantly greater in the etanercept monotherapy and combination groups than in the methotrexate monotherapy group (35.9% and 35.7% vs.
Conclusions: NLR can also be used as an alternative to BhCG for evaluating the success of single-dose methotrexate administration in treating ectopic pregnancy.
(26-29) Methotrexate toxicity is positively correlated to its absorption.
Her medications at the time of admission included methotrexate 25 mg weekly, leflunomide 10 mg daily, esomeprazole, prednisone 5 mg daily, folic acid 1 mg daily, and mirtazapine.
They were randomized to receive 0.8 mg/kg (up to 40-mg total dose) adalimumab (38 patients), 0.4 mg/kg (up to 20-mg total dose) subcutaneously at week 0 and then every other week (39 patients), or 0.1-0.4 mg/kg once weekly of oral methotrexate (up to 25 mg per week total dose; 37 patients).
Her complete blood count revealed a hemoglobin of 8.1 g/dL with MCV of 106.8 fL consistent with macrocytic anemia, platelet count of 73 x [10.sup.3]/[micro]L, WBC count of 4.0 x [10.sup.3]/[micro]L with absolute neutrophil count of 500, sodium 147mEq/L, potassium 6.0mEq/L, bicarbonate 14 mEq/L, creatinine 7.75 mg/dL, BUN 125 mg/dL, eGFR 5 ml/min/1.73 [m.sup.2], ALT 30U/L, AST 26U/L, alkaline phosphatase 56U/L, digoxin level of 1.3ng/mL, and methotrexate level of 0.27 [micro]mol/L.
They were given methotrexate (25 mg injection deep I/M once weekly) or acitretin (0.4mg/kg orally daily).
When administering methotrexate therapy, it is essential to remain aware of the risks and side effects of medical management.